Skip to main content

$0.300 -0.015 (-4.76%)

High

$0.31

Low

$0.30

Trades

7

Turnover

$48,780

Volume

160,000
30 June 2023 at 4:10pm
Register to track MAP and receive email alerts.
Subject
MAP Article: Gut health biotech Microba seeks $20m to fund UK acquisition

MAP Ann: Notification of cessation of securities - MAP

MAP Ann: Microba Commences Phase I Clinical Trial for IBD Therapeutic

MAP Ann: MRFF Grant Awarded to QUT, In Collaboration With Microba

MAP Ann: Notification of cessation of securities - MAP

MAP Ann: Microba receives two AusIndustry Advanced Overseas Findings

MAP Ann: Appendix 3Z - Final Director's Interest Notice

MAP Ann: Director Resignation

MAP Ann: Application for quotation of securities - MAP

MAP Ann: Cleansing Notice

MAP Ann: Change in substantial holding - Tiga Trading Pty Ltd

MAP Ann: Change in substantial holding from TEK

MAP Ann: Cleansing Notice

MAP Ann: Application for quotation of securities - MAP

MAP Ann: Q3 FY23 Quarterly Investor Presentation

MAP Ann: Q3 FY23 Quarterly Activities Report & Appendix 4C

MAP Ann: Details of Q3 FY23 Quarterly Report, Appendix 4C & Webinar

MAP Ann: Cleansing Notice

MAP Ann: Application for quotation of securities - MAP

MAP Ann: SYNLAB Contracts Signed in Poland, Hungary, Romania, Croatia

MAP Ann: Microba Receives Ethics Approval for Phase 1 Clinical Trial

MAP Ann: Release of Securities from Voluntary Escrow

MAP Ann: NWR Virtual Healthcare Conference Presentation

MAP Ann: Microba to present at NWR Virtual Investor Conference

MAP Ann: SYNLAB Agreements Signed in Turkiye and Czech Republic

MAP Ann: Microba Launches Next Generation Healthcare Testing

MAP Ann: H1 FY23 Interim Report

MAP Ann: ShareCafe Small Cap Hidden Gems Presentation

MAP Ann: US Distribution Agreement Signed with Luminary Health

MAP Ann: Notification regarding unquoted securities - MAP

MAP Ann: Results of General Meeting

MAP Ann: Positive first animal data for Cancer Program

MAP Ann: Q2 FY23 Quarterly Investor Presentation

MAP Ann: Q2 FY23 Quarterly Activities Report & Appendix 4C

MAP Ann: Details of Q2 FY23 Investor Webinar

MAP Ann: Letter to Shareholders, Notice of Meeting & Proxy Form

MAP Ann: SYNLAB Agreements Signed in Italy and Portugal

MAP Ann: Change in substantial holding - Tiga Trading Pty Ltd

MAP Ann: Change in substantial holding from TEK

MAP Ann: Ceasing to be a substantial holder

MAP Ann: Change in substantial holding

MAP Ann: Change in substantial holding

MAP Ann: Change in substantial holding

MAP Ann: Change in substantial holding

MAP Ann: Change in substantial holding

MAP Ann: Becoming a substantial holder from SHL

MAP Ann: Cleansing Notice

MAP Ann: Application for quotation of securities - MAP

MAP Ann: SHL: STRATEGIC STAKE AND COMMERCIAL PARTNERSHIP WITH MICROBA

MAP Ann: Proposed issue of securities - MAP

Register to track MAP and receive email alerts.